by Diane Alter
Shares of drug companies developing Ebola treatments have at turns soared and tanked over the past couple months amid speculation and hype.
But other companies not chasing after a treatment for the disease have also attracted interest amid the worst Ebola outbreak in history. One such company is Alpha Pro Tech (NYSEMKT: APT), which made penny stock news in October when shares soared to an all-time high of $10.73.
Here's a look at why APT is more than just an Ebola stock…
Here's a look at why APT is more than just an Ebola stock...
Good morning! Stock market futures for Friday, Dec. 5 forecast a 40-point increase from yesterday's close, which saw the Dow slip 0.07% to end a three-day winning streak. The market turned downward on weaker-than-expected weekly jobless claims and news that the European Central Bank will wait until January to decide on new stimulus action.
by Shah Gilani
I've talked about the dangers posed by the scary move the U.S. Treasury bond market made back on Oct. 15.
And my cautionary tale was totally justified.
Indeed, in the December 3 Wall Street Journal, the lead article in the Global Finance portion of the Money & Investing section was "Watchdog Warns of Risk in Markets."
Apparently, the Office of Financial Research (OFR), the watchdog team created out of Dodd-Frank legislation under the "watchful" eye of the U.S. Treasury Department, observed the same move that I did – and found it just as rattling.
According to The Journal, the OFR warned that "the system is vulnerable to repeats of what occurred in October when tumult in the trading of U.S. Treasury securities spread broadly to futures, swaps and options markets."
The watchdog group's just-released third annual report soberly noted that "although the dislocation that peaked in mid-October was fleeting, we believe there is a risk of a repeat occurrence," and further warned that resulting volatility "raises a host of financial stability questions."
That's not what you want to hear. Let me tell you why...
When researching the best biotech stocks to buy, investors often look for companies that will cure terrible, chronic diseases.
Until recently, these biotech stocks have been elusive. But now that's changing – thanks to an industry known as personalized medicine.
The Dow Jones today slipped 12 points, retreating from yesterday's record high.
The markets were weighed down by weak job figures and news the European Central Bank won't explore stimulus efforts until January. Volatile oil stocks also dragged down the S&P 500 and the Dow Jones.
Here are the top stories from today's trading session...
Ambarella (Nasdaq: AMBA) stock has gone on an amazing tear since we first recommended it, more than tripling in value.
But Ambarella meets and exceeds Tech Specialist Michael Robinson's Tech Wealth Secrets Rule No. 1: Great Companies Have Great Operations
With that in mind, here's why AMBA stock could double once again from here...
by David Zeiler
Bad behavior on the part of the big investment banks is almost a cliché by now, but some Wall Street lies can harm individual investors more than others.
This came to light again last week when the Financial Industry Regulatory Authority (FINRA) slapped a $15 million fine on Citigroup Inc. (NYSE: C) for giving privileged clients a much different opinion of certain stocks than the bank was publishing in its reports.
And Citi is not alone.
Here's why regulators can't stop this kind of thing, no matter how many fines they impose...
The Dow Jones today may pass the 18,000-point mark.
Here's the news driving U.S. markets today, including a DIS dividend boost, media wars, and more...
by Diane Alter
Stocks to watch today, Dec. 4, 2014: Earnings season has all but ended. Just six companies in the S&P 500 Index have yet to post results.
Thursday brings results from some key industry players, including a beleaguered bookseller, an iconic yet struggling department store chain, a leading dollar store company, and more.
Following are seven hot stocks to watch today.
Media elites and Wall Street cheerleaders are greeting lower oil prices with open arms.
Investors should beware these self-appointed experts bearing gifts.
Oil prices are falling for reasons that should be surprising to nobody: supply has been rising and demand has been falling. If prolonged, which it is likely to be, the drop in oil prices is going to be destabilizing geopolitically and damaging economically.
For those who want to believe in a magical economic rebirth as the price of oil falls, well, good luck with that.
